118 related articles for article (PubMed ID: 12363005)
1. Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773.
Schmitz FJ; Petridou J; Astfalk N; Köhrer K; Scheuring S; Schwarz S
Microb Drug Resist; 2002; 8(3):171-7. PubMed ID: 12363005
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin.
Schmitz FJ; Petridou J; Jagusch H; Astfalk N; Scheuring S; Schwarz S
J Antimicrob Chemother; 2002 Apr; 49(4):611-7. PubMed ID: 11909834
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of constitutively expressed erm(C) genes selected in vitro in the presence of the non-inducers pirlimycin, spiramycin and tylosin.
Lüthje P; Schwarz S
J Antimicrob Chemother; 2007 Jan; 59(1):97-101. PubMed ID: 17085767
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
Novotná G; Spízek J; Janata J
Folia Microbiol (Praha); 2007; 52(6):593-9. PubMed ID: 18450221
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
Shortridge VD; Zhong P; Cao Z; Beyer JM; Almer LS; Ramer NC; Doktor SZ; Flamm RK
Antimicrob Agents Chemother; 2002 Mar; 46(3):783-6. PubMed ID: 11850262
[TBL] [Abstract][Full Text] [Related]
6. Unusual inducible cross resistance to macrolides, lincosamides, and streptogramins B by methylase production in clinical isolates of Staphylococcus aureus.
Clarebout G; Nativelle E; Leclercq R
Microb Drug Resist; 2001; 7(4):317-22. PubMed ID: 11822771
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of quinupristin-dalfopristin against strains of Staphylococcus aureus with the MLS(B) phenotype of resistance according to the erm gene type.
Clarebout G; Nativelle E; Bozdogan B; Villers C; Leclercq R
Int J Antimicrob Agents; 2004 Nov; 24(5):444-9. PubMed ID: 15519475
[TBL] [Abstract][Full Text] [Related]
8. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
Morosini MI; Cantón R; Loza E; del Campo R; Almaraz F; Baquero F
J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
[TBL] [Abstract][Full Text] [Related]
9. Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci.
Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 2000 Dec; 46(6):941-9. PubMed ID: 11102413
[TBL] [Abstract][Full Text] [Related]
10. A Staphylococcus aureus plasmid that specifies constitutive macrolide-lincosamide-streptogramin B resistance contains a novel deletion in the ermC attenuator.
Catchpole I; Dyke KG
FEMS Microbiol Lett; 1990 May; 57(1-2):43-7. PubMed ID: 2116351
[TBL] [Abstract][Full Text] [Related]
11. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.
Leclercq R; Nantas L; Soussy CJ; Duval J
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():67-75. PubMed ID: 1399953
[TBL] [Abstract][Full Text] [Related]
12. Novel chromosome-encoded erm(47) determinant responsible for constitutive MLSB resistance in Helcococcus kunzii.
Guérin F; Isnard C; Bucquet F; Fines-Guyon M; Giard JC; Burrus V; Cattoir V
J Antimicrob Chemother; 2016 Nov; 71(11):3046-3049. PubMed ID: 27494920
[TBL] [Abstract][Full Text] [Related]
13. A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus.
Matsuoka M; Endou K; Kobayashi H; Inoue M; Nakajima Y
FEMS Microbiol Lett; 1997 Mar; 148(1):91-6. PubMed ID: 9066116
[TBL] [Abstract][Full Text] [Related]
14. Characteristic expression of three genes, msr(A), mph(C) and erm(Y), that confer resistance to macrolide antibiotics on Staphylococcus aureus.
Matsuoka M; Inoue M; Endo Y; Nakajima Y
FEMS Microbiol Lett; 2003 Mar; 220(2):287-93. PubMed ID: 12670694
[TBL] [Abstract][Full Text] [Related]
15. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
Walsh F; Willcock J; Amyes S
J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
Jalava J; Kataja J; Seppälä H; Huovinen P
Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
Singh KV; Malathum K; Murray BE
Antimicrob Agents Chemother; 2001 Dec; 45(12):3640-3. PubMed ID: 11709359
[TBL] [Abstract][Full Text] [Related]
18. Resistance to macrolide, lincosamide and streptogramin antibiotics in staphylococci isolated in Istanbul, Turkey.
Aktas Z; Aridogan A; Kayacan CB; Aydin D
J Microbiol; 2007 Aug; 45(4):286-90. PubMed ID: 17846580
[TBL] [Abstract][Full Text] [Related]
19. Phenotypes of staphylococcal resistance to macrolides, lincosamides and streptogramin B (MLS) in a Turkish university hospital.
Tunçkanat F; Arikan S
Zentralbl Bakteriol; 2000 Jan; 289(8):827-33. PubMed ID: 10705614
[TBL] [Abstract][Full Text] [Related]
20. Solithromycin Can Specifically Induce Macrolide-Lincosamide-Streptogramin B Resistance.
Min YH
Microb Drug Resist; 2020 Sep; 26(9):1046-1049. PubMed ID: 32216609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
